How Has the Vocal Biomarkers Market Evolved Historically and What is its Current Size?
The vocal biomarkers market has seen considerable growth due to a variety of factors.
• The vocal biomarkers market has experienced rapid growth in recent years. It is expected to grow from $2.84 billion in 2024 to $3.37 billion in 2025, at a CAGR of 18.8%.
Factors contributing to this growth include the need for early disease detection, applications of vocal biomarkers in lie detection, increased demand in the defense sector, rising mental health disorders, and the prevalence of chronic diseases like cardiovascular issues.
What Does Future Hold for The Vocal Biomarkers Market By 2029?
The vocal biomarkers market is expected to maintain its strong growth trajectory in upcoming years.
• The vocal biomarkers market is expected to grow to $6.66 billion by 2029, at a CAGR of 18.6%.
Growth is attributed to the rising incidence of neurological and psychological disorders, the demand for novel diagnostic methods, the growing incidence of dementia, and increased awareness of the potential of vocal biomarkers. Major trends include advancements in biomarker technology, high investments in R&D, improvements in diagnostic capabilities, and the ongoing evolution of medical technologies.
What Are The Primary Growth Drivers In The Vocal Biomarkers Market?
The escalating incidences of neurological and psychological disorders are anticipated to fuel the advancement of the voice biomarkers market. Neurological disorders refer to health conditions that affect the nervous system, while psychological disorders influence mood, thought process, and behavior. The rise in these disorders can be linked to factors such as increased stress levels, aging demographic, lifestyle alterations, and heightened awareness and diagnostic abilities. The application of voice biomarkers in the diagnosis and monitoring of these disorders facilitates the non-invasive detection of changes in speech patterns, pitch, and rhythm that are disease-specific. This offers critical insights into the existence and evolution of these diseases. For instance, the data released by alzheimers.gov, under US-based Department of Health and Human Services (HHS), in April 2024 revealed that over 6 million Americans aged 65 and above were diagnosed with Alzheimer’s disease. It is projected that this figure will surge to over 13 million by 2060. Moreover, the National Institution of Mental Health, a US-based National Institution of Health, reported in 2022 that of the 59.3 million adults with AMI, around 30.0 million (50.6%) received mental health treatment in the preceding year. Consequently, the burgeoning cases of neurological and psychological disorders are fuelling the expansion of the voice biomarkers market.
What Is The Segmentation Of The Global Vocal Biomarkers Market?
The vocal biomarkers market covered in this report is segmented –
1) By Type: Frequency, Amplitude, Error Rate, Vocal Rise Or Fall Time, Phonation Time, Voice Tremor, Pitch, Other Types
2) By Indications: Psychiatric Disorders, Neurological Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Other Indications
3) By Consumer: Children And Newborns, Adult
4) By End Users: Hospitals And Clinics, Academic, Research, Other End-Users
Subsegments:
1) By Frequency: Fundamental Frequency (Pitch), Formant Frequencies
2) By Amplitude: Intensity Levels: Amplitude Variation
3) By Error Rate: Phonemic Errors, Prosodic Errors
4) By Vocal Rise Or Fall Time: Rise Time Slope, Fall Time Slope
5) By Phonation Time: Sustained Phonation Duration, Phonation Intervals
6) By Voice Tremor: Frequency Modulation Tremor, Amplitude Modulation Tremor
7) By Pitch: Mean Pitch, Pitch Variability
8) By Other Types: Speech Rate, Jitter, Shimmer
Pre-Book The Vocal Biomarkers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Vocal Biomarkers Market?
Leading corporations in the vocal biomarkers market are prioritizing the creation of innovative technology, such as Monitor Vocal Biomarkers, with the aim to amplify the precision of disease identification, enhance patient supervision, and facilitate early intervention for numerous health conditions. Monitor Vocal Biomarkers denotes the application of voice examination to pinpoint physiological and psychological health indications. For example, Sonde Health, a digital health company from the US, introduced Sonde Cognitive Fitness in November 2024, which is a voice-centric cognitive fitness monitoring tool engineered to track cognitive effort in real time. This tool uses voice examples gathered through most intelligent devices, scrutinizing vocal biomarkers to gauge cognitive strain.
Who Are the Key Players In The Vocal Biomarkers Market?
Major companies operating in the vocal biomarkers market are:
• Hitachi Ltd.
• International Business Machines Corporation
• Synaptics Inc.
• Nuance Communications
• Veritone Inc.
• Axios Pro
• Cogito Corporation
• Boston Technology Corporation
• Cambridge Cognition Ltd.
• ConversationHealth
• Beyond Verbal
• AudEERING
• EVOCAL Health
• Sonde Health Inc.
• Kintsugi Health
• Ellipsis Health
• Canary Speech
• Vocalis Health
• Puretech Health
• Neurotrack Technologies Inc
What Are The Regional Insights Into The Vocal Biomarkers Market?
North America was the largest region in the vocal biomarkers market in 2023. The regions covered in the vocal biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
